Semaglutide is commonly prescribed alongside nutrition and physical activity changes to help improve blood sugar management in adults with type 2 diabetes
Brand-name medications like Ozempic and Wegovy include substantial manufacturing, marketing, and research costs reflected in retail pricing ($900-$1,400/month)
In these cases, semaglutide can provide the additional support needed to help individuals achieve their goals. While only you and your healthcare provider can decide which option is best for your situation, here are some general considerations: Oral semaglutide (Rybelsus) might be better if: You strongly prefer avoiding injections You don't mind a strict morning routine You don't take other morning medications that would interfere with the 30-minute waiting period You're primarily focused on diabetes management Injectable semaglutide (Ozempic/Wegovy) might be better if: You prefer less frequent dosing (once weekly vs
Rahman, I., Kode, A., & Biswas, S
This suggests that GLP-1 agonism may produce different effects depending on the specific brain region as well as the unique age-related changes experienced by each individual